
SOM MINI CPD: Cannabis Prescriptions with Helen Vangikar
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
- The difference between NHS-authorised cannabis-based medicinal products (per the BNF) and privately issued prescriptions.
- Why some organisations (e.g., Network Rail) will only accept BNF-listed cannabis prescriptions.
- How Medical Review Officers should handle positive test results when legitimate prescriptions are involved.
- The analytical challenges in laboratories—why they can’t distinguish private vs. street cannabis.
- The need for consistent policy development across sectors and internationally.
- The role of CBD vs. THC in testing and future trends in testing approaches and legal frameworks.
Resources & Links
- Helen Vangikar’s website: helenvangikar.com
- Connect with Helen on LinkedIn: LinkedIn Profile
- Society of Occupational Medicine (SOM): som.org.uk
- Faculty of Occupational Medicine (FOM): fom.ac.uk
The SOM podcast is sponsored by Orchid Live - specialist occupational health software used by a number of SOM members to run every aspect of their occupational health operations. They hold healthcare records for over 1 million UK workers and work with both in-house OH teams and OH providers. You can find out more at OrchidLive.com.
Pas encore de commentaire